Beste apotheek van Nederland

Padma-Nathan H, Goldstein I, Klimberg I et al. Long-term
safety and efficacy of oral phentolamine mesylate (Vasomax) in
men with mild to moderate erectile dysfunction. Int J Impot Res
2002;14(4):266-270.
Padma-Nathan H, McMurray J G, Pullman W E et al. Ondemand
IC351 (Cialis) enhances erectile function in patients
with erectile dysfunction. Int J Impot Res 2001;13(1):2-9.
Padma-Nathan H, Montorsi F, Giuliano F et al. Vardenafil
restores erectile function to normal range in men with erectile
dysfunction. Br J Sex Med 2007;4(1):152-161.
Pagani E, Glina S, Puech-Leao P et al. Anxiety and high plasma
catecholamines do not impair pharmaco-induced erection of
psychogenic erectile dysfunctional patients. Int J Impot Res
2003;15(4):282-286.
Pagani E, Puech-Leao P, Glina S et al. The value of a second
injection on the pharmaco-induced erection test. Int J Impot Res
1997;9(3):167-168.
Pallas James, Levine Stephen B, Althof Stanley E et al. A study
using Viagra in a mental health practice. [References]. J Sex
Marital Ther 2000;26(1):41-50.
Palumbo F, Bettocchi C, Selvaggi F P et al. Sildenafil: efficacy
and safety in daily clinical experience. Eur Urol 2001;40(2):176­
180.
Pangkahila W I. Evaluation of transurethral application of
alprostadil for erectile dysfunction in Indonesians. Asian J
Androl 2000;2(3):233-236.
Park K, Ku J H, Kim S W et al. Risk factors in predicting a poor
response to sildenafil citrate in elderly men with erectile
dysfunction. BJU Int 2005;95(3):366-370.
Parkerson George R J, Willke Richard J, Hays Ron D. An
international comparison of the reliability and responsiveness of
the Duke Health Profile for measuring health-related quality of
life of patients treated with alprostadil for erectile dysfunction.
Med Care 1999;37(1):56-67.
Penninga E, Jensen B A, Hansen P B et al. Anagrelide treatment
in 52 patients with chronic myeloproliferative diseases. Clinical
& Laboratory Haematology 2004;26(5):335-340.
Perimenis P, Athanasopoulos A, Geramoutsos I et al. The
incidence of pharmacologically induced priapism in the
diagnostic and therapeutic management of 685 men with erectile
dysfunction. Urol Int 2001;66(1):27-29.
Perimenis P, Athanasopoulos A, Papathanasopoulos P et al.
Gabapentin in the management of the recurrent, refractory,
idiopathic priapism. Int J Impot Res 2004;16(1):84-85.
Perimenis P, Markou S, Gyftopoulos K et al. Switching from
long-term treatment with self-injections to oral sildenafil in
diabetic patients with severe erectile dysfunction. Eur Urol
2002;41(4):387-391.
Pescatori E S, Calpista A, Artibani W et al. Selfinjection
devices for intracavernosal pharmacotherapy:
operational classification and safety considerations. Int
J Impot Res 1996;8(2):53-57.
Peskircioglu L, Tekin M I, Demirag A et al.
Evaluation of erectile function in renal transplant
recipients. Transplant Proc 1998;30(3):747-749.
Peterson C A, Bennett A H, Hellstrom W J et al.
Erectile response to transurethral alprostadil, prazosin
and alprostadil-prazosin combinations. Br J Urol
1998;159(5):1523-1527.
Petrov V I, Vekel'yan A S, Martyushev A V et al.
Impaza and Sildenafil: Comparison of Clinical
Effectiveness in Patients with Erectile Dysfunction.
Bull Exp Biol Med 2003;135-136(Suppl 1):150-151.
Petty R, Angwin R. How real is the male menopause?.
Br J Gen Pract 2004;248(1659):452-456.
Pierce L J, Whittington R, Hanno P M et al.
Pharmacologic erection with intracavernosal injection
for men with sexual dysfunction following irradiation:
a preliminary report. Int J Radiat Oncol Biol Phys
1991;21(5):1311-1314.
Pohanka M, Kanovsky P, Bares M et al. The longlasting
improvement of sexual dysfunction in patients
with advanced, fluctuating Parkinson's disease
induced by pergolide: evidence from the results of an
open, prospective, one-year trial. Parkinsonism Relat
Disord 2005;11(8):509-512.
Pohanka M, Kanovsky P, Bares M et al. Pergolide
mesylate can improve sexual dysfunction in patients
with Parkinson's disease: the results of an open,
prospective, 6-month follow-up. Eur J Neurol
2004;11(7):483-488.
Polak K, Wimpissinger B, Berisha F et al. Effects of
sildenafil on retinal blood flow and flicker-induced
retinal vasodilatation in healthy subjects. Invest
Ophthalmol Vis Sci 2003;44(11):4872-4876.
Pomara G, Morelli G, Montorsi F et al. Re: Montorsi
F, Salonia A, Briganti A, Barbieri L, Zanni G, Surdi
N, Cestari A, Montorsi P, Rigatti P. Vardenafil for the
treatment of erectile dysfunction: A critical review of
the literature based on personal clinical experience.
Eur Urol 2005;47:612-21 (multiple letters). Eur Urol
2005;48(2):345-346.
Pomara G, Morelli G, Pomara S et al. Cardiovascular
parameter changes in patients with erectile
dysfunction using pde-5 inhibitors: a study with
sildenafil and vardenafil. J Androl 2004;25(4):625­
629.
D-178